Do you want to read an article? Please log in or register.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Diabetes - GeneralObesity and Bariatric Surgery
COMMENTED
Related content
COMMENTED
Obesity and Bariatric Surgery
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
JAMA
Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D, STEP 4 Investigators.
doi: 10.1001/jama.2021.3224
Type 2 DiabetesObesity and Bariatric Surgery
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Diabetes Care
Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P
doi: 10.2337/dc20-2151
Diabetes - GeneralObesity and Bariatric Surgery
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year
Diabetes Obes Metab.
Lundkvist P, Pereira MJ, Katsogiannos P, Sjöström CD, Johnsson E, Eriksson JW
doi: 10.1111/dom.12954.
Type 1 DiabetesObesity and Bariatric Surgery
Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
Diabetes Obes Metab.
Ghanim H, Batra M, Green K, Abuaysheh S, Hejna J, Makdissi A, Borowski R, Kuhadiya N, Chaudhuri A, Dandona P
doi: 10.1111/dom.14090.
COMMENTED
Obesity and Bariatric Surgery
Six Weeks of Morning Fasting Causes Little Adaptation of Metabolic or Appetite Responses to Feeding in Adults with Obesity
Obesity (Silver Spring).
Chowdhury EA, Richardson JD, Gonzalez JT, Tsintzas K, Thompson D, Betts JA
doi: 10.1002/oby.22452.
Obesity and Bariatric Surgery
The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating and gastric emptying in subjects with obesity
Diabetes Obes Metab
Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D
doi: 10.1111/dom.14280
Diabetes - General
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Lancet.
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JPH
doi: 10.1016/S0140-6736
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Diabetes Care.
Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR
doi: 10.2337/dc17-0417.
COMMENTED
Obesity and Bariatric Surgery
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Lancet.
NCD Risk Factor Collaboration (NCD-RisC)
doi: 10.1016/